Back to the main directory
Press Release
- Agrify Corporation Announces Turnkey Extraction Equipment Deal with Multi-State Operator Justice Cannabis Co. Expanding into New Jersey Market by GlobeNewsWire
- Cibus to Participate in the 36th Annual Roth Conference by GlobeNewsWire
- Frequency Electronics Announces 3rd Quarter Financial Results Conference Call: Thursday, March 14, 2024, at 4:30 PM ET by GlobeNewsWire
- Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD) by GlobeNewsWire
- Hepsiburada to Announce Fourth Quarter and Full Year 2023 Results on March 25, 2024 by GlobeNewsWire
- Muutos johtoryhmässä: Kaapro Kanto jättää tehtävänsä Aktian tietohallintojohtajana by GlobeNewsWire
- AB Science: New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven neurodegenerative disease by GlobeNewsWire
- Recce Pharmaceuticals to Present at the American Society for Clinical Pharmacology & Therapeutics (ASCPT) 2024 Annual Meeting by GlobeNewsWire
- Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA by GlobeNewsWire
- IMUNON Files IND Application to Begin Human Testing of IMNN-101 by GlobeNewsWire
- Spectral AI Schedules 2023 Fourth Quarter and Full Year Financial Results and Conference Call by GlobeNewsWire
- MIMEDX Introduces E-Commerce and Account Management Platform by GlobeNewsWire
- Vera Bradley Announces Fourth Quarter and Fiscal Year 2024 Results by GlobeNewsWire
- Perma-Fix Achieves 36% Year-Over-Year Increase in Revenue to $22.7 Million for the Fourth Quarter of 2023 by GlobeNewsWire
- CHAR Tech and Lake Nipigon Forest Management Inc. Sign Partnership Agreement by GlobeNewsWire
- Lightbridge Announces Upcoming Nuclear Events by GlobeNewsWire
- Ocugen, Inc. Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 1 of Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410 by GlobeNewsWire
- Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting by GlobeNewsWire
- PDD Holdings to Report Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results on March 20, 2024 by GlobeNewsWire
- TMC Commends U.S. Congress on Bill to “Provide Financial, Diplomatic, or Other Forms of Support for Seafloor Nodule Collection, Processing and Refining” and Advancing International Regulations for Seafloor Resources by GlobeNewsWire
- Annual General Meeting 2024 – GN Store Nord A/S by GlobeNewsWire
- Form 8.3 - Urban Logistics REIT plc by GlobeNewsWire
- Sangamo Therapeutics Announces Data From Novel Proprietary Neurotropic AAV Capsid Demonstrating Industry-leading Blood-brain Barrier Penetration and Brain Transduction in NHPs by BusinessWire
- Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results by BusinessWire
- PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments by GlobeNewsWire
- Clearmind Medicine Received Approval for a Voluntary Delisting of its Common Shares From the Canadian Securities Exchange by GlobeNewsWire
- EQS-News: DISCLOSURE OF THE TOTAL NUMBER OF VOTING RIGHTS AND CAPITAL, IN ACCORDANCE WITH THE LAW AND GRAND-DUCAL REGULATION OF 11 JANUARY 2008 ON TRANSPARENCY REQUIREMENTS FOR ISSUERS, AS AMENDED by EQS Group AG
- Solid Biosciences Provides Fourth Quarter and Full-Year 2023 Business Update and Financial Results by GlobeNewsWire
- Installed Building Products Announces Plans to Refinance and Extend its Term Loan B Facility by BusinessWire
- Change in Executive Committee: Kaapro Kanto leaves his duties as Chief Information Officer at Aktia by GlobeNewsWire
- Ändringar i Aktias ledningsgrupp: Kaapro Kanto lämnar uppdraget som direktör för Aktias dataförvaltning by GlobeNewsWire
- AB Science : De nouvelles recherches montrent que le masitinib limite les dommages neuronaux dans un modèle de maladie neurodégénérative d’origine neuroimmune by GlobeNewsWire
- PDS Biotech Announces Publication of Preclinical Research and Grant of U.S. Composition of Matter Patent for Infectimune® by GlobeNewsWire
- STRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024 by GlobeNewsWire
- Worksport to Advance Power Electronics with Gallium Nitride Semiconductors, improving on Silicone-Based Technology by GlobeNewsWire
- CEO of Innovative Outcomes, Inc., (OTC:UBQU) Offers Open Letter to Shareholders and Investors by GlobeNewsWire
- INmune Bio CSO and Co-Founder Mark Lowdell, Ph.D. Receives The ISCT Career Achievement Award in Cell and Gene Therapy by GlobeNewsWire
- Fresh Vine Wine Merger Partner Notes Live Chooses McKinney, TX for Largest Venue Yet: Iconic 20,000-Capacity, State-of-the-Art Concert Amphitheater by GlobeNewsWire
- Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting by GlobeNewsWire
- TransUnion Technology Transformation Reaches Next Phase with Introduction of OneTru™, a Platform Built for AI-Powered Data Collaboration by GlobeNewsWire
- Clene Reports Full Year 2023 Financial Results and Recent Operating Highlights by GlobeNewsWire
- BranchOut Food to Debut New Products at Natural Products Expo West by GlobeNewsWire
- Asia Broadband’s Second Gold-Backed NFT Collection the “Golden Rascals” Are Now In The Final Minting Phase and Listed on the Solana Blockchain by GlobeNewsWire
- Ferroglobe Appoints Carsten Larsen as Chief Commercial Officer by GlobeNewsWire
- vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update by GlobeNewsWire
- Form 8.3 - UK Commercial Property REIT by GlobeNewsWire
- Bridger Aerospace Announces Schedule for its Fourth Quarter 2023 Earnings Release and Conference Call by GlobeNewsWire
- RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit by BusinessWire
- Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical Trial by GlobeNewsWire
- Four XPO Leaders Named 2024 “Pros to Know” by Supply & Demand Chain Executive Magazine by GlobeNewsWire